DWQA Questions › Tag: hereditary angioedema
Filter:AllOpenResolvedClosedUnanswered
Intellia Therapeutics just reported positive Phase 3 clinical trial results for its experimental treatment for hereditary angioedema, a rare condition causing sudden and sometimes dangerous swelling in different parts of the body. The one-time treatment edits a gene inside the body. A single dose reduced swelling attacks by 87% and many patients had no attacks at all during the 6-month study period. Will this be a clinical success, and the first of many such therapies based on gene-editing CRISPR technology?
ClosedNicola asked 3 hours ago • 
7 views0 answers0 votes
Ask Question